Immunotherapy: A useful strategy to help combat multidrug resistance-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immunotherapy: A useful strategy to help combat multidrug resistance

Published:2012-02 Issue:1-2 Volume:15 Page:106-113
ISSN:1368-7646
Container-title:Drug Resistance Updates
language:en
Short-container-title:Drug Resistance Updates

Author:

Curiel Tyler J.

Funder

Voelcker Foundation

the Holly Beach Public Library Association

1RC2 AG036613

5P30CA54174

Texas STARS

the Owens Foundation

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Cancer Research,Pharmacology,Oncology

Reference69 articles.

1. Tumor-necrosis-factor and DNA topoisomerase-ii inhibitors in human ovarian-cancer – potential role in chemotherapy;Aluigi;Int. J. Oncol.,1995

2. Harnessing dendritic cells in cancer;Apetoh;Semin. Immunol.,2011

3. Immunogenicity of anthracyclines: moving towards more personalized medicine;Apetoh;Trends Mol. Med.,2008

4. Molecular interactions between dying tumor cells and the innate immune system determine the efficacy of conventional anticancer therapies;Apetoh;Cancer Res.,2008

5. CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy;Azab;Blood,2009

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Minimalist “in situ” tumor vaccine leveraging versatile dendrimer nanoplatform coordinated ICD and immunoagonist for boosted chemoimmunotherapy;Science China Materials;2024-06-14

2. Using nanotechnology to progress the utilization of marine natural products in combating multidrug resistance in cancer: A prospective strategy;Journal of Biochemical and Molecular Toxicology;2024-05-20

3. Acquired immune resistance is associated with interferon signature and modulation of KLF6/c‐MYB transcription factors in myeloid leukemia;European Journal of Immunology;2024-03-11

4. Molecular Mechanism of Multi‐Drug Resistant Cancer Cells;Multi‐Drug Resistance in Cancer;2023-07-17

5. Multidrug Resistance in Cancer: Understanding Molecular Mechanisms, Immunoprevention and Therapeutic Approaches;Frontiers in Oncology;2022-06-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3